COMMUNIQUÉS West-GlobeNewswire

SciSparc: Subsidiary NeuroThera Labs Completes C$5.4 Million Financing with SciSparc’s Stake Valued at Approximately C$30 Million
18/08/2026
SciSparc Invests C$2.7 million and holds approximately 44.6% of NeuroThera’s issued and outstanding common shares following the financing TEL AVIV, Israel, Aug. 18, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC [...]
Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom
18/08/2026
Initial three-year term includes minimum annual license commitments PETACH TIKVA, ISRAEL, August 18 2026 -- Nanox Imaging Ltd. (“ Nanox”, or the “Company” NASDAQ: NNOX), a leader in innovative medical imaging technology [...]
Pliant Therapeutics Receives FDA Fast Track Designation for PLN-101095 in Combination with Pembrolizumab for the Treatment of ICI-Refractory Solid Tumors
18/08/2026
SOUTH SAN FRANCISCO, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced the receipt of Fast Track designation from the U.S. Food and Drug Administration (FDA) for PLN- [...]
Vivos Inc. Achieves Two Major Operational Milestones: First IsoPet® Shipments from New U.S. Production Facility and Authorization from India’s Nuclear Regulatory Authority for International Manufacturing Center
18/08/2026
Kennewick, WA, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a medical device company pioneering Precision Radionuclide Therapy ™ (PRnT) for the treatment of cancerous tumors, today announced two [...]
Propanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP
18/08/2026
Avance Clinical to Lead Preparatory Activities for Multi-Center Investigation Across Australia MELBOURNE, Australia, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company [...]
ENvue Medical Announces Exclusive UroShield® Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million
18/08/2026
Multi-year agreement with Peak Medical expands UroShield commercialization across the United Kingdom and Republic of Ireland TYLER, Texas, Aug. 18, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) (“ENvue” or the “ [...]
Polomar Health Services Reports Second-Quarter Revenue of $1.53 Million and Positive Net Income
18/08/2026
Commercial prescription fulfillment drives significant revenue growth, a 61.2% gross margin and improved operating cash flow PALM HARBOR, Fla., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Polomar Health Services, Inc. (OTCQB: [...]
Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration
18/08/2026
Peer-reviewed research points to the extracellular matrix, the framework that holds tissue together, as central to that work. More than a decade of research has gone into Conexeu’s CXU™ Platform Highlights Regenerative [...]
Akari Therapeutics Builds Momentum for AKTX-101 with Compelling Urothelial Cancer Data Supporting Differentiated ADC Strategy
18/08/2026
AKTX-101 demonstrated robust anti-tumor activity across multiple clinically relevant urothelial cancer preclinical models Data supports the potential of Akari’s novel PH1 RNA spliceosome-modulating payload to overcome [...]
BioPorto activates the first US clinical site as part of the ProNephro AKI® U.S. Adult Urine NGAL Validation Study.
18/08/2026
August 18, 2026 Press Release BioPorto activates the first US clinical site as part of the ProNephro AKI ® U.S. Adult Urine NGAL Validation Study. COPENHAGEN, DENMARK, August 18, 2026 – BioPorto A/S (“BioPorto” or “ [...]
Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors
18/08/2026
Dr. Ernest Brings Significant Value-based Care and Clinical Expertise ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its [...]
New LogicMark Survey Reveals Safety Concerns of Gen Z Women & Workarounds They've Adapted
18/08/2026
National Survey of 1,500 Gen Z Women Finds Near-Universal Vigilance, Widespread Drink-Tampering Fear, Outfit Tax on Everyday Safety, and Reporting Gap That Keeps Silence as the Norm LOUISVILLE, Ky., Aug. 18, 2026 (GLOBE [...]
R1 to Acquire Humata Health, Enhancing Phare OS with AI-Powered Prior Authorization Automation and Payer-Provider Collaboration
18/08/2026
Acquisition Removes Friction from Complex Prior Authorizations to Benefit Patients, Clinicians, Providers, and Payers CHICAGO, Aug. 18, 2026 (GLOBE NEWSWIRE) -- R1 (“R1” or the “Company”), an industry leader in [...]
Oncolytics Biotech® Aligns with FDA on Registrational Path for Second-Line RAS-Mutant MSS Colorectal Cancer
18/08/2026
FDA written feedback provides alignment on a potential pivotal Part B expansion of the ongoing REO 033 study Proposed pathway offers potential accelerated approval based on objective response rate and progression-free [...]
Citizen Health Partners with Sofie’s Journey to Lead the RARE Epilepsy Arena at the 14th Annual Epilepsy Awareness & Education Expo
18/08/2026
Rare epilepsy families will have a dedicated home at the largest gathering of epilepsy physicians and patients in the world, with expanded access to specialists and to Ari, Citizen Health’s AI teammate for patients and [...]
Precision Optics Appoints Peter Thier as Senior Vice President of Sales and Marketing
18/08/2026
Strategic appointment strengthens commercial leadership and supports expansion across medical, defense and aerospace markets LITTLETON, Mass., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq [...]
Florida Board of Medicine Approves the National Board of Physicians and Surgeons (NBPAS) as a Recognizing Agency
18/08/2026
The decision is expected to expand patient access to care and allow NBPAS-certified physicians to accurately advertise their board certification credentials in Florida. LA JOLLA, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE [...]
Syneos Health Advances AI-Powered Clinical Ecosystem to Optimize Trial Performance and Speed Decision-Making
18/08/2026
Expanding Set of Partners and Proprietary Insights Strengthens Operational Performance MORRISVILLE, N.C., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Syneos Health ® , a leading fully integrated biopharmaceutical solutions [...]
DARÉ Bioscience CEO Sabrina Martucci Johnson Named to Forbes 2026 “50 Over 50: Innovation” List
18/08/2026
National recognition comes as Daré Bioscience advances a multi-product women’s health strategy across commercialization, clinical development and first-in-category innovation SAN DIEGO, Aug. 18, 2026 (GLOBE NEWSWIRE [...]

Pages